PAVmed Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PAVmed Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- PAVmed Inc. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- PAVmed Inc. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $841.00K, a 69.90% increase year-over-year.
- PAVmed Inc. stock issued during period, value, new issues for the quarter ending 2024-12-31 was $331.00K, a 49.70% decline year-over-year.
- PAVmed Inc. stock issued during period, value, new issues for fiscal 2024 was $1.31M, a 28.29% decline from fiscal 2023.
- PAVmed Inc. stock issued during period, value, new issues for fiscal 2023 was $1.82M.
- PAVmed Inc. stock issued during period, value, new issues for fiscal 2018 was $4.27M.
- PAVmed Inc. stock issued during period, value, new issues for fiscal 2016 was $3.95M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.17M derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $1.46M derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-03-31 | $841.00K 10-Q · filed 2025-05-15 | $1.65M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-12-31 | $331.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $1.31M 10-K · filed 2025-03-24 |
| 2024-09-30 | $284.00K 10-Q · filed 2025-11-12 | $1.64M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $198.00K 10-Q · filed 2025-08-14 | $1.35M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $495.00K 10-Q · filed 2025-05-15 | $1.76M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $658.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $1.82M 10-K · filed 2025-03-24 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | |
| 2023-06-30 | $609.00K 10-Q · filed 2024-08-12 | |
| 2023-03-31 | $557.00K 10-Q · filed 2024-05-13 | |
| 2020-03-31 | $2.80M 10-Q · filed 2020-05-28 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-14 | $4.27M 10-K · filed 2020-04-14 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-19 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | |
| 2018-03-31 | $4.27M 10-Q · filed 2018-05-21 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $3.95M 10-K · filed 2018-03-14 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InspireMD, Inc. (NSPR) | $0.033B | ||
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |